Cost-utility analysis of a malignant glioma protocol

International Journal of Radiation Oncology Biology Physics

Volumn 39, Issue 3, 1997, Pages 575-578

  Konski, Andre ^a,b,d   Bracy, Paula ^a   Weiss, Steven ^a   Grigsby, Perry ^c  

^a UNIVERSITY OF TOLEDO   (United States)

^b TOLEDO HOSPITAL   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d USA   (United States)

Author keywords

Cost utility analysis; Malignant gliomas; Quality adjusted life years (QALY); Quality adjusted survival

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; COST; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; ECONOMIC ASPECT; GLIOBLASTOMA; HEALTH CARE COST; HUMAN; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RADIATION DOSE; REIMBURSEMENT;

EID: 0030981684     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00373-8     Document Type: Article

References (16)

1. Bauman, G. S.; Gaspar, L. E.; Fisher, B. J.; Halperin, E. C.; MacDonald, D. R; Cairncross, J. G. A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. Int. J. Radiat. Oncol. Biol. Phys. 29:835-839; 1994.
2. Detsky, A. S.; Naglie, I. G. A clinician's guide to cost-effectiveness analysis. Ann. Int, Med. 113:147-154; 1990.
3. Federal Register, Thursday, September 1, vol. 59. 1994; 169: 45368-45457.
4. Federal Register, Thursday, December 8, vol. 59. 1994; 235: 63555-63634.
5. Hsiao, W. C.; Braun, P.; Dunn, D. Resource-based relative values: An overview. JAMA. 260:2418-2424; 1988.
6. Hsiao, W. C.; Yntema, D. B.; Braun, P.; Dunn, D.; Spencer, C. Measurement and analysis of intraservice work. JAMA 260: 2361-2370; 1988.
7. Mackworth N.; Fobair, P.; Prados, M.D. Quality of life self-reports from 200 brain tumor patients: Comparisons with Karnofsky performance scores. J. Neurooncol. 14:243-253; 1992.
8. Murray, K. J.; Nelson, D. F.; Scott, C.; Fischbach, A. J.; Porter, A.; Farnan, N.; Curran, W. J. Quality-adjusted survival analysis of malignant glioma patients treated with twice-daily radiation (RT) and carmustine: A report of Radiation Therapy Oncology Group (RTOG) 83-02. Int. J. Radiat. Oncol. Biol. Phys. 31:453-459; 1995.
9. Nelson, D. F.; Curran, W. J.; Scott, C.; Nelson, J. S.; Weinstein, A. S.; Ahmad, K; Constine, L. S.; Murray, K.; Powlis, W. D.; Mohiuddin, M.; Fischbach, J. Hyperfractionated radiation therapy and bis-chlorethyl nitrosurea in the treatment of malignant glioma - Possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: Report of the Radiation Therapy Oncology Group Protocol 8302. Int. J. Radiat. Oncol. Biol. Phys. 25:193-207; 1993.
10. Nord, E. Methods for quality adjustment of life years. Soc. Sci. Med. 34:559-569; 1992.
11. Peschel, R.; Wilson, L.; Haffty, B.; Papdopoulos, D.; Rosenzweig, K.; Feltes, M. The effect of advanced age on the efficacy of radiation therapy for early breast cancer, local prostate cancer and Grade III-IV gliomas. Int. J. Radiat. Oncol. Biol. Phys. 26:539-544; 1993.
12. Sachsenheimer, W.; Piotrowski, W.; Bimrnler, T. Quality of life in patients with intracranial tumors on the basis of Karnofsky's performance status. J. Neurooncol. 13:177-181; 1992.
13. Schulman, K. A.; Yabroff, K. R. Measuring the cost-effectiveness of cancer care. Oncology 9:523-533; 1995.
14. Shepard, D. S.; Thompson, M. S. First principles of cost-effective analysis in health. Pub. Health Rep. 94:535-543; 1979.
15. Trojanowski, T.; Peszynski, J.; Turowdki, K. Quality of survival of patients with brain gliomas treated with postoperative CCNU and radiation therapy. J. Neurosurg. 70:18-23; 1989.
16. Weinstein, M. C.; Statson, W. B. Foundations of cost-effectiveness analysis for health and medical practices. N. Engl. J. Med. 296:716-721; 1977.